11L. Genetics of biological processes Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Genetics of development: development potentials (totipotent, pluripotent, multipotent, unipotent), cell differentiation

A
  • Totipotent: all the cell types in a body, plus the extraembryonic, or placental, cells (zygote - fertilized egg)
  • Pluripotent: all of the cell types that make up the body (inner cell mass, epiblast, stem cells)
  • Multipotent: can develop into more than one cell type, but are more limited (endo-, meso-, ectoderm)
  • Unipotent: can develop into only one type of cell or tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Significance of stem cells

A

1) Tissues/cells for therapy
2) Drug development and toxicity tests
3) Experiments to study development and gene control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Role of morphogens and their concentration gradient (Sonic hedgehog)

A

Morphogens

  • Soluble signalling molecules with concentration gradient in eggs or developing embryos
  • Act differently on same target cell types depending on location and concentation
  • Example: embryonic cranio-caudal axis or proximo-distal axis of lims are due to conc. grad. of morphogens
  • Become different cells in response to different concentration of morphogens (e.g 1ng/ml activin -> muscle cells, while 10 ng/ml -> notochord cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sonic Hedgehog

A
  • Coding a morphogen (signalling molecule)
  • Protein expressed in notocord and later in central cells of VENTRAL neural tube
  • Involved in development of CNS, muscle, limbs and in lateralization and eye development (polyphemos)
    *Small amount of SHH => sensory neuron
    Medium/lots of SHH => motor neuron at different locations
    **Mutants lacking SHH have no motor neurons=>die
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Genetics of sex: sex determination

A

1) Genetic
- Sex chromosomes
- SRY and other genes
2) Environmental
- Temperature
- Body mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Genetics of sex: male sex determination

A

SRY gene

  • Binds to and bends DNA - regulates genes that control development of testis
  • Affect Sertoli cells -> AMH (anti-Mullerian hormone) -> inhibit female differentiation
  • Affect Leydig cells -> Testosterone -> induce male sexual differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Genetics of sex: causes of maldevelopment

A

1) Sex reversion
- XX -> male: SRY has been transferred to X chr
- XY -> female: SRY has been lost from Y chr
* Cause: abnormal crossing-over during male gametogenesis (meiosis I)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Oncogenes

A
  • Dominant mutations, usually somatic
  • Gain-of-function mutation in proto-oncogene (only one allele must be mutated)
  • Most common: RAS oncogene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tumor suppressor genes, LOH

A
  • Recessive mutation in cellular level, but they often result in a dominantly inherited predisposition
  • Loss-of-function mutation (both alleles must be mutated, but still more common than gain-of-function mutation)

LOH: loss of heterozygosity
- Often found in cancers

*Most common: p53 tumor suppressor gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tumor mutator genes

A
  • Play a role in DNA repair, germline and somatic mutations

- Dominantly inherited predisposistion - or - AR tumorigenic syndrome may be caused

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Activation mechanisms of oncogenes

A

1) Amplification (too many gene copies)
- Double minute chromosomes (DMs)
- ecDNA (extrachromosomal DNA) is found in nearly half of cancers and contributes to intrantumoral heterogeneity (mostly driver oncogenes - e.g MYC)
* Genes in cancer can be amplified in chromosomes or in circular ecDNA including double minutes

2) Point mutations
- Ex: Gly12Val of H-Ras

3) Chromosome translocation results in chimeric protein
- Philadelphia chromosome (med: imatinib/Gleevec)

4) Insertion of a retrovirus derived promoter/enhancer into the proximity of an oncogene
5) Oncogene hypomethylation (epigenetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Immunogenetics: somatic gene rearrangement

A

Light chain

  • V-JC: DNA splicing (lambda)
  • V-J: DNA splicing (kappa)
  • VJ-C intron excision (RNA splicing)

Heavy chain

  • D-J: DNA splicing
  • V-DJ: DNA splicing
  • VDJ-C intron excision (RNA splicing)
  • RNA splicing: from the 3rd membrane-bound C domain of IgM to 3rd soluble C domain
  • Class switch: DNA splicing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Immunogenetics: role of epigenetics

A

Epigenetic disease: DNMT3B (de novo methyltransferase mutation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immunogenetics: genetic background of antibody diversity

A

Fra nett:

1) Germ line theory: each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen;
2) Somatic mutation theory: antibody-producing cells contain only a few genes, which produce antibody diversity by mutation
3) Gene rearrangement theory: antibody diversity is generated by the rearrangement of variable region gene segments during the differentiation of the antibody-producing cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cell reprogramming + future applications

A

Cell reprogramming is the process of reverting mature, specialised cells into induced pluripotent stem cells
- Induced pluripotent stem cells (iPS)

Future applications:

  • Autologous cell therapies
  • Allogenic cell therapies
  • Disease modeling
  • Drug screening
  • Transplantation studies
  • Maybe: self-fertilization, same-sex fertilization if epigenetic alterations are added
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Major applications for iPS

A

1) Age-related macular degeneration (retinal pigment epithelium)
2) Parkinson’s disease (A9 dopaminergic neuron)
3) Spinal cord injury (oligodendrocyte progenitor)
4) Diabetes (β-cell progenitor)
5) Myocardial infarction (cardiomyocytes)

17
Q

Maternal effect genes

A

Expressed in mother during oogenesis and acting on or within maturing oocytes

18
Q

Gap genes -> pair-rule genes -> segment polarity genes

A

Segmentation genes expressed after fertilization.
Modify either the number or polarity of segments.
Act one-after-the-other and determine smaller and smaller regions of the embryo

19
Q

Homeotic genes (HOX genes)

A

Master regulatory genes (most important)

  • Regulate segment identity w/o influencing the number, polarity and size of segments
  • Mutation: “kroppsdeler på feil sted” - e.g polydactylia
  • All such genes contain a homeobox sequence (!)
  • Code transcription factors that regulates expression of other genes
  • Spatial co-linearity kept between species: the genes are expressed the same way along ant-post axis
20
Q

Dorsal and ventral gradients needed for normal neuron differentiation

A

Ventral: SHH (sonic hedgehog)
Dorsal: TGF-β family

21
Q

Apoptosis inducing and inhibiting factors

A

Inducing: BMP (bone morphogenetikus protein
Inhibiting: Gremlin
*Only in chicken/ducks?

22
Q

Genes in male vs female differentiation

A

Female

  • No SRY -> no inhibition of RSPO1
  • RSPO1 inhibit SOX9 => no testis
  • WNT4: promotes female and represses male

Male

  • Have SRY -> inhibition of RSPO1
  • SOX9 uninhibited => testis
  • FGF9 also needed for male development (activated by SOX9 -> feedforward loop)
23
Q

Disorders caused by HOX gene mutations

A
  • Polydactylia
  • Hand-foot-genitals syndrome
  • Synpolydactylia
  • Cleft palate
  • Brain abnormalities
  • Uterus abnormalities
  • Retinoic acid acting on HOX genes causes developmental abnormalities
24
Q

Teratorgens types + effect

A

1) Synteratogens: not effective alone, only in combination with another chemical
2) Proteratogens: only the metabolite is effective

Effect depends on:

1) Dose
2) Sensitivity
- Genetic background (SNPs)
- Developmental period (teratogenic window)

25
Q

Abnormalities in female offspring due to maternal DES exposure

A

1) Vaginal or cervical cancer (adenocarcinoma)
2) Uterine/vaginal malformations
- Sterility/infertility
- Spontaneous abortions
- Premature birth
- Stillbirth
- Ectopic pregnancy
* DES also increase risk of breast cancer

26
Q

Inheritance tumor risk

A

< 10% Mendelian inheritance

BUT genotype affect our overall cancer risk!

27
Q

Heritable oncogene mutations

A

RET gene, cause

  • MEN2A (multiple endocrine neoplasia)
  • FMTC (familial medullary thyroid cancer)

K-RAS - germline activating mutations, cause
- Noonan syndrome -> increased risk for myeloid leukemia

28
Q

Epigenetics in cancer

A

1) Hypermethylation of TSG or mutator genes
2) Chromatin remodeling
3) Telomerase activity (?)
4) Drugs, chemicals, hormones etc

29
Q

Epigenetic profiling in diagnosis and prognosis

A

MGMT: brain biopsy, prediction of drug response

GSTP1: urine system biopsy, tumor detection

30
Q

Loss of imprinting (LOI) in cancer

A
  • IGF2 (normally paternal allele expressed)

- > colon cancer when maternal also expressed

31
Q

Development of a colon cancer cell

A

I rekkefølge

1) APC (chr5) => increased cell growth
2) DNA loses methyl groups (epigenetic) => Polyp (low)
3) K-RAS mutation => Polyp (mid level)
4) Loss of MCC amd DCC (chr18) => Polyp (high level)
5) Loss of p53 (chr 17) => Malignant tumor
6) Other chromosome losses => metastases

32
Q

Human papilloma virus

A
  • Can increase cancer risk
  • No oncogene in them! But the virus proteins alter the expression of their own genes
  • Some proteins encoded by early viral genes bind p53 and RB TSGs and inhibit them
33
Q

Transmissible cancer

A

1) DFTD: Devil facial tumor disease
- MHC I and II lack functional diversity - avoid immune system recognition
2) CTVT: Canine transmissible venereal tumor
- Progressive phase: no MHC, but TGF1
- Regressive phase: MHC I and II

34
Q

Primary T cell immunodeficiencies

A

1) SCID-X1
2) JAK3 deficiency
3) Adenosine deaminase deficiency